MediWound (MDWD) EBT Margin (2014 - 2025)

MediWound's (MDWD) quarterly EBT Margin came in at 417.78% in Q4 2025, down 31331.0% year-on-year from N/an in Q4 2024, and down 247.61% quarter-over-quarter from 120.19% in Q3 2025.

MediWound (MDWD) EBT Margin (2014 - 2025) Analysis & Trends

MediWound's EBT Margin history runs 12 years deep, the most recent figure standing at 417.78% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 31331.0% year-over-year to 417.78% in Q4 2025; TTM through Dec 2025 was 252.44%, a 12549.0% decrease from a year earlier, with the FY2025 full-year figure at 140.93%, up 850.0% from the prior year.
  • EBT Margin eased to 417.78% in Q4 2025 per MDWD's latest filing, from 120.19% in the prior quarter.
  • Across five years, EBT Margin topped out at 76.95% in Q2 2023 and bottomed at 757.13% in Q2 2025.
  • The 5-year median for EBT Margin is 108.85% (2021), against an average of 157.14%.
  • Across the five-year window, EBT Margin surged 33758 bps in 2023 and sank 48176 bps in 2024, its largest moves.
  • Year by year, EBT Margin stood at 75.74% in 2021, then climbed by 16 bps to 63.63% in 2022, then surged by 52 bps to 30.4% in 2023, then sank by 244 bps to 104.47% in 2024, then sank by 300 bps to 417.78% in 2025.
  • Per Business Quant, the three latest MDWD EBT Margin figures stand at 417.78% (Q4 2025), 120.19% (Q3 2025), and 757.13% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MediWound 183.16 Mn 178.36 Mn 278,000.00 -417.78%

Historic Data

Download Data
DateValue
Dec 31, 2025 -417.78%
Sep 30, 2025 -120.19%
Jun 30, 2025 -757.13%
Mar 31, 2025 -132.11%
Dec 31, 2024 -104.47%
Sep 30, 2024 -116.67%
Jun 30, 2024 -404.81%
Mar 31, 2024 -75.22%
Dec 31, 2023 -30.40%
Sep 30, 2023 -44.97%
Jun 30, 2023 76.95%
Mar 31, 2023 -97.08%
Dec 31, 2022 -63.63%
Sep 30, 2022 -72.27%
Jun 30, 2022 -260.64%
Mar 31, 2022 -81.35%
Dec 31, 2021 -75.74%
Sep 30, 2021 -126.36%
Jun 30, 2021 -125.68%
Mar 31, 2021 -113.22%